Summary by Moomoo AI
Lawrence Lamb, EVP and CSO of In8bio, Inc. (INAB), was reported to have engaged in a transaction involving the company's stock on February 7, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of the shares, were not disclosed in the announcement. The report also did not provide information on the number of shares held by Lamb after the transaction. The transaction is of interest to investors who follow insider activity as an indicator of the company's health and potential future performance.